User:JonSDSUGrad/Sandbox/TEST7 PTGS2

From Wikipedia, the free encyclopedia


prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
Identifiers
Symbol(s) PTGS2; COX2; PGG/HS; COX-2; PGHS-2; PHS-2; hCox-2
External IDs OMIM: 600262 MGI97798 HomoloGene31000
Orthologs
Human Mouse
Entrez 5743 19225
Ensembl ENSG00000073756 ENSMUSG00000032487
Uniprot P35354 n/a
Refseq NM_000963 (mRNA)
NP_000954 (protein)
NM_011198 (mRNA)
NP_035328 (protein)
Location Chr 1: 184.91 - 184.92 Mb Chr 1: 151.86 - 151.87 Mb
Pubmed search [1] [2]

[edit] Summary

Prostaglandin-endoperoxide synthase (PTGS), also known as cyclooxygenase, is the key enzyme in prostaglandin biosynthesis, and acts both as a dioxygenase and as a peroxidase. There are two isozymes of PTGS: a constitutive PTGS1 and an inducible PTGS2, which differ in their regulation of expression and tissue distribution. This gene encodes PTGS2, which shows 86% - 89% amino acid sequence identity with mouse, rat, sheep, bovine, horse and rabit PTGS2 proteins, respectively. Human PTGS2 is expressed in a limited number of cell types and regulated by specific stimulatory events, suggesting that it is responsible for the prostanoid biosynthesis involved in inflammation and mitogenesis. The expression of this gene is deregulated in epithelial tumors.[1]

[edit] References

[edit] Further reading

  • Richards JA, Petrel TA, Brueggemeier RW (2002). "Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.". The Journal of steroid biochemistry and molecular biology 80 (2): 203-12. PMID 11897504. 
  • Koki AT, Khan NK, Woerner BM, Seibert K, Harmon JL, Dannenberg AJ, Soslow RA, Masferrer JL (2003). "Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers.". Prostaglandins, leukotrienes, and essential fatty acids 66 (1): 13-8. doi:10.1054/plef.2001.0335. PMID 12051953. 
  • Saukkonen K, Rintahaka J, Sivula A, Buskens CJ, Van Rees BP, Rio MC, Haglund C, Van Lanschot JJ, Offerhaus GJ, Ristimaki A (2003). "Cyclooxygenase-2 and gastric carcinogenesis.". APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 111 (10): 915-25. PMID 14616542. 
  • Sinicrope FA, Gill S (2004). "Role of cyclooxygenase-2 in colorectal cancer.". Cancer metastasis reviews 23 (1-2): 63-75. PMID 15000150. 
  • Jain S, Khuri FR, Shin DM (2004). "Prevention of head and neck cancer: current status and future prospects.". Current problems in cancer 28 (5): 265-86. PMID 15375804. 
  • Saba N, Jain S, Khuri F (2004). "Chemoprevention in lung cancer.". Current problems in cancer 28 (5): 287-306. PMID 15375805. 
  • Cardillo I, Spugnini EP, Verdina A, Galati R, Citro G, Baldi A (2006). "Cox and mesothelioma: an overview.". Histology and histopathology 20 (4): 1267-74. PMID 16136507. 
  • Brueggemeier RW, Díaz-Cruz ES (2006). "Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.". Minerva endocrinologica 31 (1): 13-26. PMID 16498361. 
  • Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K (2006). "Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience.". World journal of gastroenterology : WJG 12 (9): 1336-45. PMID 16552798. 
  • Bingham S, Beswick PJ, Blum DE, Gray NM, Chessell IP (2007). "The role of the cylooxygenase pathway in nociception and pain.". Seminars in cell & developmental biology 17 (5): 544-54. doi:10.1016/j.semcdb.2006.09.001. PMID 17071117.